1. Home
  2. NPO vs SRRK Comparison

NPO vs SRRK Comparison

Compare NPO & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enpro Inc.

NPO

Enpro Inc.

HOLD

Current Price

$255.29

Market Cap

5.3B

Sector

Industrials

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$44.00

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPO
SRRK
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.6B
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
NPO
SRRK
Price
$255.29
$44.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$278.33
$55.40
AVG Volume (30 Days)
182.6K
1.3M
Earning Date
05-05-2026
03-03-2026
Dividend Yield
0.52%
N/A
EPS Growth
N/A
N/A
EPS
1.91
N/A
Revenue
$1,532,000,000.00
N/A
Revenue This Year
$12.31
N/A
Revenue Next Year
$6.39
$449.79
P/E Ratio
$129.32
N/A
Revenue Growth
16.98
N/A
52 Week Low
$133.50
$22.71
52 Week High
$286.35
$49.82

Technical Indicators

Market Signals
Indicator
NPO
SRRK
Relative Strength Index (RSI) 50.30 49.87
Support Level $208.99 $41.54
Resistance Level $286.35 $48.29
Average True Range (ATR) 9.61 2.52
MACD -0.78 0.09
Stochastic Oscillator 69.56 55.43

Price Performance

Historical Comparison
NPO
SRRK

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: